Physician profile
Travis P Webb
NPI 1760434062
$1,833.68
in general payments reported to CMS, 2019-2025
17 companies · $694 in 2025
The $694 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2021: $528 · 2023: $21.11 · 2024: $444 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $485.88 | 2021 | |
| Avita Medical Americas, LLC | $332.61 | 2024-2025 | Recell |
| Kerecis Limited | $150.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $142.25 | 2024-2025 | Novosorb Btm |
| Allergan, INC. | $137.27 | 2019 | |
| Access Pro Medical, LLC | $136.83 | 2025 | Matriderm |
| Smith+Nephew, INC. | $124.89 | 2024 | Collagenase Santyl, Acticoat 4" X 4", Oasis |
| Ethicon US, LLC | $118.78 | 2024-2025 | Vistaseal, Enseal |
| Boston Scientific Corporation | $42.00 | 2021 | |
| Haemonetics Corporation | $31.51 | 2025 | Teg6s Hemostasis System |
| Polymedics Innovations INC. | $27.30 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.97 | 2025 | |
| Integra Lifesciences Corporation | $21.11 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Atricure, INC. | $17.73 | 2024 | |
| Reprise Biomedical, INC. | $16.04 | 2025 | Miro3d |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $14.36 | 2024 | Giapreza |
| Kls-Martin L.P. | $9.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.